97. Ulcerative colitis
2,269 clinical trials,   1,331 drugs   (DrugBank: 241 drugs),   114 drug target genes,   181 drug target pathways

Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00572585
(ClinicalTrials.gov)
April 201012/12/2007Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative ColitisA Randomized, Double Blind, Placebo Controlled, Parallel Group Design Study to Explore the Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative ColitisUlcerative ColitisDrug: AEB071;Drug: PlaceboNovartis PharmaceuticalsNULLCompleted18 Years75 YearsAll60Phase 2United States;Denmark;Germany;Poland
2EUCTR2007-002542-38-DK
(EUCTR)
28/11/200708/11/2007A clinical study to explore the safe and effective use of the drug sotrastaurin in patients with ulcerative colitisA randomized, double blind, placebo controlled, parallel group design study to explore the efficacy, safety and tolerability of AEB071 in patients with active, moderate to severe ulcerative colitis. - A2210 Ulcerative colitis
MedDRA version: 14.0;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 10017947 - Gastrointestinal disorders;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Name: Sotrastaurin
Product Code: AEB071
INN or Proposed INN: Sotrastaurin (INN) acetate
Product Name: Vitamin B2
INN or Proposed INN: Riboflavin
Novartis Pharma Services AGNULLNot RecruitingFemale: yes
Male: yes
60Phase 2Denmark;Germany
3EUCTR2007-002542-38-DE
(EUCTR)
29/10/200722/02/2008A clinical study to explore the safe and effective use of the drugsotrastaurin in patients with ulcerative colitisA randomized, double blind, placebo controlled, parallel group design study to explore the efficacy, safety and tolerability of AEB071 in patients with active, moderate to severe ulcerative colitis. Ulcerative colitis
MedDRA version: 14.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 10017947 - Gastrointestinal disorders;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Code: AEB071A
Trade Name: B2-ASmedic
Product Name: B2-ASmedic
INN or Proposed INN: RIBOFLAVIN
Novartis Pharma Services AGNULLNot RecruitingFemale: yes
Male: yes
60Denmark;Germany